BACKGROUND: Younger age at first birth and greater parity generally reduce the risk of developing breast cancer, but whether this reduced risk holds in women with a mutation in the BRCA1 or BRCA2 gene is unknown. METHODS: In a Washington DC community-based study conducted in 1996, we tested 5318 Ashkenazi Jews for three BRCA1/2 founder mutations and identified 120 mutation carriers. Applying an extension of the "kin-cohort" analysis, we compared the effects of reproduction on breast cancer risk in carriers and noncarriers. We also used a case-case analysis among 288 participants who had been diagnosed with breast cancer. RESULTS: In noncarriers, the estimated relative risk (RR) of breast cancer rose 5% with each 5-year increment in age at first birth (RR = 1.05; 95% confidence interval [CI] = 0.97-1.15). By contrast, the estimated risk in mutation carriers fell with each 5-year increment in age (RR = 0.65; 95% CI = 0.37-1.16). Among the 288 participants who were breast cancer survivors themselves, the comparison of carriers with noncarriers also showed no protection associated with early birth in the presence of a mutation in BRCA1 or BRCA2. CONCLUSIONS: It is not yet clear whether the recognized breast cancer risk factors operate in the same way in women who carry a mutation in the BRCA1 or BRCA2 genes.
BACKGROUND: Younger age at first birth and greater parity generally reduce the risk of developing breast cancer, but whether this reduced risk holds in women with a mutation in the BRCA1 or BRCA2 gene is unknown. METHODS: In a Washington DC community-based study conducted in 1996, we tested 5318 Ashkenazi Jews for three BRCA1/2 founder mutations and identified 120 mutation carriers. Applying an extension of the "kin-cohort" analysis, we compared the effects of reproduction on breast cancer risk in carriers and noncarriers. We also used a case-case analysis among 288 participants who had been diagnosed with breast cancer. RESULTS: In noncarriers, the estimated relative risk (RR) of breast cancer rose 5% with each 5-year increment in age at first birth (RR = 1.05; 95% confidence interval [CI] = 0.97-1.15). By contrast, the estimated risk in mutation carriers fell with each 5-year increment in age (RR = 0.65; 95% CI = 0.37-1.16). Among the 288 participants who were breast cancer survivors themselves, the comparison of carriers with noncarriers also showed no protection associated with early birth in the presence of a mutation in BRCA1 or BRCA2. CONCLUSIONS: It is not yet clear whether the recognized breast cancer risk factors operate in the same way in women who carry a mutation in the BRCA1 or BRCA2 genes.
Authors: Nadine Andrieu; David E Goldgar; Douglas F Easton; Matti Rookus; Richard Brohet; Antonis C Antoniou; Susan Peock; Gareth Evans; Diana Eccles; Fiona Douglas; Catherine Noguès; Marion Gauthier-Villars; Agnès Chompret; Flora E Van Leeuwen; Irma Kluijt; Javier Benitez; Brita Arver; Edith Olah; Jenny Chang-Claude Journal: J Natl Cancer Inst Date: 2006-04-19 Impact factor: 13.506
Authors: Jenny N Poynter; Bryan Langholz; Joan Largent; Lene Mellemkjaer; Leslie Bernstein; Kathleen E Malone; Charles F Lynch; Ake Borg; Patrick Concannon; Sharon N Teraoka; Shanyan Xue; Anh T Diep; Therese Törngren; Colin B Begg; Marinela Capanu; Robert W Haile; Jonine L Bernstein Journal: Cancer Causes Control Date: 2010-02-04 Impact factor: 2.506
Authors: Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Charmaine Kim-Sing; Susan Neuhausen; Rochelle Demsky; William D Foulkes; Parviz Ghadirian; Nadine Tung; Peter Ainsworth; Leigha Senter; Beth Karlan; Andrea Eisen; Charis Eng; Jeffrey Weitzel; Dawna M Gilchrist; Joanne L Blum; Dana Zakalik; Christian Singer; Taya Fallen; Ophira Ginsburg; Tomasz Huzarski; Ping Sun; Steven A Narod Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-05-07 Impact factor: 4.254
Authors: Antonis C Antoniou; Andrew Shenton; Eamonn R Maher; Emma Watson; Emma Woodward; Fiona Lalloo; Douglas F Easton; D Gareth Evans Journal: Breast Cancer Res Date: 2006 Impact factor: 6.466
Authors: Laufey Tryggvadottir; Elinborg J Olafsdottir; Sigfridur Gudlaugsdottir; Steinunn Thorlacius; Jon G Jonasson; Hrafn Tulinius; Jorunn E Eyfjord Journal: Breast Cancer Res Date: 2003-06-24 Impact factor: 6.466